Company profile
INSMED INC
NASDAQ:INSMBiotechnology: Pharmaceutical Preparations
Drug pipeline (3)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| BRINSUPRI | approved | $309.2MQ2 2026 | 16 | approved |
| ARIKAYCE KIT | approved | $116.3MQ2 2026 | 0 | — |
| IPLEX | approved | — | 2 | approved |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (50)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05673603 | phase1 | completed | 2021-07-20 | 2023-02-14 | Insmed Incorporated | A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment |
| NCT04791514 | phase2 | terminated | 2022-03-29 | 2022-08-26 | Insmed Incorporated | A Study of Treprostinil Palmitil Inhalation Powder (TPIP) In Pulmonary Arterial Hypertension (PAH) |
| NCT05652257 | phase1 | completed | 2021-08-13 | 2021-09-14 | Insmed Incorporated | A Study of the Absorption, Metabolism, and Excretion of [14C]-Brensocatib Following a Single Oral Administration in Healthy Male Participants |
| NCT06685835 | phase2 | terminated | 2024-12-16 | 2026-02-12 | Insmed Incorporated | A Study of the Efficacy and Safety of Brensocatib in Adults With Moderate to Severe Hidradenitis Suppurativa (HS) |
| NCT06013241 | phase2 | completed | 2023-10-30 | 2025-09-30 | Insmed Incorporated | A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP) |
FDA applications (3)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| NDA 217673 | 2025-08-12 | NDA | INSMED INC | |||||
Loading… | ||||||||
| NDA 207356 | 2018-09-28 | NDA | INSMED INC | |||||
Loading… | ||||||||
| BLA 021884 | 2005-12-12 | BLA | INSMED INCORPORATED | |||||
Loading… | ||||||||